- Akcea and Pfizer Inc. Announce Licensing Agreement for investigative antisense therapy AKCEA-ANGPTL3-L(Rx) GlobeNewswire
- After leadership shuffle, Akcea hands heart drug to Pfizer for $250M FierceBiotech
- Here's Why Akcea Therapeutics Jumped 30% Today The Motley Fool
- Pfizer to Develop Akcea/Ionis Antisense Candidate for Up to $1.5B Genetic Engineering & Biotechnology News
- What Happened in the Stock Market Today Motley Fool
- View full coverage on Google News
https://ift.tt/eA8V8J
Hello, my name is Jack Sparrow. I'm a 50 year old self-employed Pirate from the Caribbean. 
No comments:
Post a Comment